Skip To Main Content
Bwalya A. Witika on Muck Rack

Bwalya A. Witika

As seen in: MDPI, Royal Society of Chemistry, Health SA Gesondheid
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Bwalya A.

Contact Bwalya A., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Development of 225 Ac PSMA617-TFA Poly(Lactic-co-glycolic)acid Nanoparticles and Their Potential Use in Targeted Alpha Therapy

|
By Bwalya A. Witika, Honest Ndlovu, Yonwaba Mzizi
| preprints.org
You are already at the latest version Background: Actinium-225 (225Ac) is receiving major attention as the radionuclide of choice for targeted alpha therapy (TAT) due to its outstanding physical properties such as a long physical half-life of 9.9 days and a short range of alpha (α)- particles which are responsible for the destruction of malignant tumours, whilst sparing normal surrounding tissues.
Open in Who Shared Issue with article?

Antimicrobial Management of Skin and Soft Tissue Infections among Surgical Wards in South Africa: Findings and Implications

|
By Bwalya A. Witika, Atlanta B. Makwela, Wandisile M. Grootboom, Veena Abraham
| MDPI
Abstract : Skin and soft tissue infections (SSTIs) are one of the most common infectious diseases requiring antibiotics. However, complications of SSTIs may lead to the overprescribing of antibiotics and to subsequent antibiotic resistance. Consequently, monitoring the prescribing alignment with the current recommendations from the South African Standard Treatment Guidelines (STG) is necessary in order to improve future care.
Open in Who Shared Issue with article?

A SWOT analysis of nano co-crystals in drug delivery: present outlook and future perspectives

|
By Bwalya A. Witika, Yahya E Choonara, Patrick H. Demana
| Royal Society of Chemistry Verified
A SWOT analysis of nano co-crystals in drug delivery: present outlook and future perspectives Bwalya A. Witika, *a Yahya E. Choonarab and Patrick H. Demanaa Abstract The formulation of poorly soluble drugs is an intractable challenge in the field of drug design, development and delivery. This is particularly problematic for molecules that exhibit poor solubility in both organic and aqueous media.
Open in Who Shared Issue with article?
See all 4 articles